There are many reasons for those of us who have retired from the business of university management to be grateful no longer to have to worry about how best to steer our universities through whatever rough seas the shifting winds of politics and economics put in their way. As I’ve said in previous entries, I don’t envy today’s Vice Chancellors having to contend with the current pandemic and its future repercussions on top of the perennial problem of transient cabinet ministers intent on to leaving their mark on the system before they move on to a more significant portfolio. But recent events have made me particularly pleased no longer to be implicated in any way in a global academic research system which is, in one aspect at least, unforgivably wasteful and exploitative, and is arguably profoundly immoral.
Where the UK is concerned, we still have one of the most productive and highly regarded university systems in the world, although there is no question that Brexit is bound to wreak very serious, and possibly irreparable, damage on it. An impressive array of outstanding research, disproportionate to the size our system, still comes out of our universities, but it does so at incalculable cost. Most of that cost is entirely hidden, both at the national and individual institutional levels. The figures for the monies distributed by the six UK Research Councils (see the table from the THES above) amounted in 2017-18 to rather under £1.2bn; a roughly equivalent amount will have been distributed to Higher Education on the basis of the most recent Research Excellence Framework (REF). That is the visible cost where the Research Councils are concerned. Some idea of the invisible cost, literally invisible, is arrived at by the simple expedient of subtracting the number of successful grants, 1,793, from the number of applications, 6,959. So 5,226 bids that will each have taken literally hundreds of hours to put together, and will have carried the hopes, and sometimes the livelihoods, of their authors with them, have all been an abject waste of time and talent. ‘Livelihoods’ because far too many researchers around the world are obliged to live a frighteningly precarious existence from one successful funding grant to the next. Much of the cost is unquantifiable as it relates to mental health, wellbeing and general quality of life.
That, if course, is only half of the problem where government funding of universities in UK is concerned. The other half lies with the countless more hours that have to be spent preparing for the regular cycle of REF evaluations; hours spent administering and writing about research rather than doing it. And then there are all the other non-governmental funding bodies that, to their great credit, fund academic research, but in the process compound the problem where the wholly unproductive time and energy expended on unsuccessful funding bids is concerned. This is often time and energy expended by many of the ablest men and women in the country that could have been spent far more productively.
Why write about this right now? Because over the past nine months I have spent a significant amount of time painstakingly proofreading and commenting on an excellent collaborative research bid being produced by a group of researchers from, among others, Brown University and the University of Pennsylvania, whose principal investigator was from the University of Cape Town. The proposal to one of the major medical research funding bodies in the United States was for the funding of the evaluation of a potentially really important behavioural intervention designed to try to address the significant number of young men in the Western Cape (and, ultimately, elsewhere) who test positive for HIV but don’t then move to treatment. The intervention involves a short video to be used when they are being counselled on first receipt of their HIV-positive result. The video, whose production was funded by the Bill and Melinda Gates Foundation, features brief interviews with HIV positive men on antiretroviral treatment trying to address stigma and fears about antiretrovirals by talking about the normality of the lives they are able to lead.
The bid was not funded at initial submission, but the reviews were largely very positive, detailed comments were received from the reviewers, and the researchers were invited to resubmit. A huge amount of work went into making sure all the comments were addressed and the bid was duly resubmitted. The devastating news came through on Tuesday that the resubmission had been rejected without further review. No reasons given; apparently no appeal possible; literally hundreds and hundreds of hours wasted, not just the time of those preparing the bid but also that of the initial reviewers. The funding body would have been perfectly within its rights to change its funding policies in the interim to focus, for example, on Coronavirus instead of HIV/AIDS, but if that is what has happened it is wholly indefensible for them not to have communicated that to researchers whom they had invited to resubmit a bid on HIV.
A better way needs to be found globally for funding academic research, some way that does not result in the livelihoods and wellbeing of academic researchers becoming collateral damage, and so much of the time and energy of some of our ablest minds being entirely wasted.